Cat #: EK-256_KIT
Size: 18 Vials
Form: Lyophilized
A-192621 Cat #: A-360
Size:
1 mg
Source: Synthetic
MW: 558.68
Purity: >97% (HPLC)
Effective concentration
0.1-10 nM.
Activity
A-192621 is a selective antagonist of ET-B endothelin receptors, inhibiting ET-1 binding to ETA and ET-3 binding to ETB receptors with IC50 values of 4280 nM and 4.5 nM, respectively1.
In vivo, A-192621 inhibits ETB-mediated dilatory and pressor responses induced by Sarafotoxin 6c (ED50 = 30 mg/kg), and causes an elevation of arterial blood pressure and plasma ET-1 level2.
In vivo, A-192621 inhibits ETB-mediated dilatory and pressor responses induced by Sarafotoxin 6c (ED50 = 30 mg/kg), and causes an elevation of arterial blood pressure and plasma ET-1 level2.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored desiccated at -20°C.
Reconstitution
Soluble in DMSO or NaOH 1Eq. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
ACT-132577 Cat #: A-350
Size:
5 mg
Source: Synthetic
MW: 546.19
Purity: >98%
Effective concentration
1-100 µM.
Activity
ACT-132577, a metabolite of macitentan, is a dual antagonist of ET-A and ET-B endothelin receptors, inhibiting binding of 125I-ET-1 to recombinant ET-A and ET-B receptors with IC50 values of 3.4 nM and 987 nM, respectively1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored desiccated at -20°C.
Reconstitution
Soluble in DMSO with gentle warming. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
Atrasentan Cat #: A-455
Size:
1 mg
Source: Synthetic
MW: 510.62
Purity: >98%
Effective concentration
0.01-10 nM.
Activity
Atrasentan is a potent and highly selective antagonist of ET-A endothelin receptors, exhibiting a 1000-fold selectivity for ET-A over ET-B receptors, inhibiting endothelin-1 radioligand binding with an IC50 of 0.36 nM and endothelin-1-stimulated phosphoinositol hydrolysis with IC50 of 0.16 nM1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
Avosentan Cat #: A-355
Size:
5 mg
Source: Synthetic
MW: 479.51
Purity: >99%
Effective concentration
0.1-100 nM.
Activity
Avosentan is a selective antagonist of ET-A endothelin receptors, shown to significantly inhibit endothelin-1-induced contractions in isolated porcine ciliary arteries at 10 nM-1 µM1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
BMS 182874 hydrochloride Cat #: B-500
Size:
5 mg
Source: Synthetic
MW: 381.88
Purity: >99%
Effective concentration
100 nM – 10 µM.
Activity
BMS 182874 hydrochloride is a potent, selective and competitive antagonist of ET-A endothelin receptors. It exhibits a 1000-fold selectivity for ET-A over ET-B receptors, inhibiting endothelin-1 radioligand binding to ET-A and ET-B with Ki of 61 nM and >50 µM, respectively. In vitro, BMS 182874 inhibits endothelin-1 induced calcium mobilization with KB of 140 nM1. BMS 182874 is orally bioavailable and active in vivo1,2.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at +4°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
BQ788 Cat #: B-175
Size:
0.5 mg
Source: Synthetic
MW: 641.81
Purity: >95%
Effective concentration
10-100 nM.
Activity
BQ788 is a potent and highly specific ET-B receptor antagonist, exhibiting selectivity for ET-B over ET-A human receptors when inhibiting the binding of [125I]-Endothelin-1 (IC50 of 1.2 nM and 1300 nM, respectively)1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO and ethanol. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
BQ788 sodium salt Cat #: B-176
Size:
0.5 mg
Source: Synthetic
MW: 663.79
Purity: >95%
Effective concentration
10-100 nM.
Activity
BQ788 is a potent and highly specific ET-B receptor antagonist, exhibiting selectivity for ET-B over ET-A human receptors when inhibiting the binding of [125I]-Endothelin-1 (IC50 of 1.2 nM and 1300 nM, respectively)1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored desiccated at -20°C.
Reconstitution
Soluble in DMSO and ethanol. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
BQ-123 sodium salt Cat #: B-185
Size:
5 mg
Source: Synthetic
MW: 632.69
Purity: >98%
Effective concentration
10 nM – 10 µM.
Activity
BQ-123, a cyclic peptide provided as a sodium salt, is a potent and selective antagonist of ET-A endothelin receptors, exhibiting a 1000-fold selectivity for ET-A over ET-B receptors (inhibiting endothelin-1 radioligand binding to ET-A and ET-B with IC50 of 22 nM and 18 µM, respectively). In vitro, BQ-123 inhibits endothelin-1 induced contractions of porcine coronary artery with KB of 40 nM1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored desiccated at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
Darusentan Cat #: D-265
Size:
5 mg
Source: Synthetic
MW: 410.43
Purity: >99%
Effective concentration
1 nM – 1 µM.
Activity
Darusentan is a selective antagonist of ET-A Endothelin receptors, inhibiting Endothelin-1 radioligand binding to ET-A and ET-B receptors with Ki of 6 nM and 371 nM, respectively1. in vitro Darusentan inhibits Endothelin-induced vascular contractility in isolated endothelium-denuded rat aortic rings with pA2 of 8.12. Darusentan is orally bioavailable and active in vivo3.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
FR 139317 Cat #: F-180
Size:
5 mg
Source: Synthetic
MW: 604.75
Purity: >99%
Effective concentration
1 nM – 1 µM.
Activity
FR 139317 is a potent and selective antagonist of ET-A receptors, inhibiting Endothelin-1 radioligand binding to ET-A and ET-B with Ki of 1 nM and 7.3 µM, respectively1. in vitro, FR 139317 shifted Endothelin-1-induced contractile response curve to the right with pA2 of 7.2 in isolated rabbit aorta2.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored desiccated at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
IRL 2500 Cat #: I-190
Size:
5 mg
Source: Synthetic
MW: 573.69
Purity: >97%
Effective concentration
0.1-10 µM.
Activity
IRL 2500 is a potent antagonist of endothelin ET-B receptors, exhibiting selectivity for ET-B over ET-A receptors when inhibiting the binding of [125I]-Endothein-1 (IC50 of 1.3 nM and 94 nM, respectively). IRL 2500 attenuates the effects of ETB-selective agonists in vitro and in-vivo, such as saraphotoxin S6c-mediated dog saphenous vein contraction or IRL-1620-induced transient decrease in arterial pressure and increase in renal vascular resistance in rat1,2.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored desiccated at -20°C.
Reconstitution
Soluble in NaOH. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
PD-156707 Cat #: P-305
Size:
5 mg
Source: Synthetic
MW: 528.49
Purity: >99%
Effective concentration
1-100 nM.
Activity
PD-156707 is a potent and selective antagonist of the ET-A Endothelin receptors, inhibiting Endothelin-1 radioligand binding to ET-A and ET-B receptors with Ki of 0.17 nM and 133.8 nM, respectively. in vitro, PD-156707 inhibits ET-A and ET-B receptor-mediated arterial vasoconstriction with pA2 of 7.5 and 4.7, respectively. PD-156707 is orally bioavailable and active in vivo1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
PD-164333 Cat #: P-310
Size:
0.5 mg
Source: Synthetic
MW: 823.63
Purity: >98%
Effective concentration
1-100 nM.
Activity
PD-164333 is a selective antagonist of the ET-A receptors, inhibiting Endothelin-1 radioligand binding to ET-A and ET-B receptors with Kd of 0.99 nM and 2.41 µM, respectively. in vitro, PD164333 shifts Endothelin-1 concentration-response curve to the right with pA2 of 8.84 in isolated human saphenous vein1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
Ro46-8443 Cat #: R-185
Size:
1 mg
Source: Synthetic
MW: 609.69
Purity: >95%
Effective concentration
0.1-10 µM.
Activity
Ro 46-8443 is a non-peptide, selective and competitive antagonist of ET-B receptors. It shows over 100-fold selectivity for human ET-B in competitive binding assays (IC50 of 34-69 nM), and competitively inhibits the binding of selective ET-B agonist [125I]Sarafotoxin-S6c to porcine trachea membranes (IC50 = 4.9 nM)1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Up to 100 mM in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
SB209670 Cat #: S-205
Size:
0.5 mg
Source: Synthetic
MW: 520.53
Purity: >95%
Effective concentration
0.2-20 nM.
Activity
SB209670 is a potent mixed antagonist of ET-A and ET-B Endothelin receptors, shown to inhibit Endothelin-1 radioligand binding to human ET-A and ET-B with Ki of 0.2 nM and 18 nM, respectively. SB209670 inhibits Endothelin-1-evoked vasoconstriction in isolated vascular tissues in vitro, and is orally bioavailable and active in vivo1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
Sitaxsentan Cat #: S-186
Size:
5 mg
Source: Synthetic
MW: 454.9
Purity: >99% (HPLC)
Effective concentration
1-100 nM.
Activity
Sitaxsentan is a potent and selective antagonist of ET-A Endothelin receptors, inhibiting Endothelin-1 radioligand binding to human ET-A and ET-B receptors with IC50 of 1.4 nM and 9.8 µM, respectively (a 7000-fold selectivity). in vitro, Sitaxsentan inhibits Endothelin-1 induced phosphoinositide turnover with a pA2 of 8.01. Sitaxsentan is orally bioavailable and active in vivo1,2.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
TAK-044 Cat #: SPE-320
Size:
5 mg
MW: 927 Da
Purity: ≥98% (HPLC)
Net peptide content: 100%
Origin
Synthetic
Effective concentration
0.5 – 1 µM.
Activity
TAK-044 is a non-selective endothelin receptor antagonist1.
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
Storage after reconstitution
Up to four weeks at 4°C or three months at -20°C.
Zibotentan Cat #: Z-130
Size:
5 mg
Source: Synthetic
MW: 424.43
Purity: >95%
Effective concentration
1 nM – 10 µM.
Activity
Zibotentan is a selective antagonist of ET-A Endothelin receptors, inhibiting Endothelin-1 radioligand binding to human ET-A with IC50 of 21 nM (whilst showing no effect on ET-B at 10 µM). Zibotentan is orally bioavailable and active in vivo.1
Storage before reconstitution
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
Reconstitution
Soluble in DMSO. Centrifuge all products before use (10000 x g 5 min).
Storage after reconstitution
Up to three months at -20°C.
For more information, please refer to individual certificate of analysis for each product.
For research purposes only, not for human use